Results 81 to 90 of about 39,719 (247)

A laboratóriumi diagnosztika eredményei az elmúlt 20 évben kórismézett 155 phaeochromocytoma/paraganglioma szindrómás beteg adatainak elemzése alapján. [PDF]

, 2015
INTRODUCTION: Laboratory diagnosis of pheochromocytoma-paraganglioma syndrome has been markedly improved during the past two decades. AIM: Retrospective assessment of diagnostic utility of urinary catecholamines and their metabolites as well as serum ...
Balog B, Gláz, Edit, Igaz, Péter, Kiss, Róbert, Patócs, Attila Balázs, Pusztai, Péter, Rácz, Károly, Róna, Kálmán, Szücs, Nikolette, Sármán, Beatrix, Tóth, Miklós, Tőke, Judit   +11 more
core   +1 more source

Cervical Small Cell Neuroendocrine Carcinoma Initially Detected on Cytology: Diagnostic Pitfalls and Clues

Cytopathology, EarlyView.
This case describes the initial detection of cervical small cell neuroendocrine carcinoma on conventional endometrial and cervicovaginal liquid‐based cytology. Given its rarity and high aggressiveness, early recognition and rapid, intensive treatment are crucial for improving patient outcomes.
Yesul Jeong
wiley   +1 more source

When Small Cells Matter: Diagnosing Bladder Small Cell Carcinoma on Urine Cytology

Cytopathology, EarlyView.
Small cell carcinoma of the bladder is rare, aggressive and diagnostically challenging on urine cytology. We report a case detected in urine and confirmed by cell block immunohistochemistry, highlighting the importance of careful assessment and limitations of the Paris System.
Haley Corbin, Samer Khader, Gabriela Quiroga‐Garza, Liron Pantanowitz   +3 more
wiley   +1 more source

Low sensitivity of chromogranin A in the diagnosis of insulinoma: a single-center study

Alʹmanah Kliničeskoj Mediciny
Background: Insulinoma is a neuroendocrine tumor (NET), with its main clinical manifestation being the hypoglycemic syndrome. The symptoms of hypoglycemia are nonspecific, and therefore, in most cases, the diagnosis is made untimely. The Russian clinical
Marina Y. Yukina, Ekaterina A. Troshina, Nurana F. Nuralieva, Olga Y. Rebrova, Larisa V. Nikankina, Natalia G. Mokrysheva   +5 more
doaj   +1 more source

Lung cancer: Clinical implications [PDF]

Journal of Medical Biochemistry, 2007
Lung cancer is the most frequent malignancy among men, and the second frequent among women (after breast cancer). Clinical calssification of lung cancer to non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) type reflects their different
Jovanović Dragana
doaj  

Chromogranin A in cardiovascular endocrinology [PDF]

Acta Physiologica, 2021
Jens P. Goetze, Linda M. Hilsted, Jens F. Rehfeld   +2 more
openaire   +3 more sources

Advances and Challenges in the Multidisciplinary Treatment of Retroperitoneal Infantile Fibrosarcoma in Early Life

European Journal of Haematology, EarlyView.
ABSTRACT Background and Aims Retroperitoneal Infantile Fibrosarcoma (RIFS) is a rare, locally aggressive pediatric soft tissue tumor. Its retroperitoneal location poses challenges due to proximity and potential invasion of critical structures such as the inferior vena cava (IVC).
Gaia Brunetti, Angelo Zarfati, Giorgio Persano, Giuseppe Maria Milano, Ida Russo, Gian Luigi Natali, Rita Alaggio, Alessandro Crocoli, Chiara Grimaldi   +8 more
wiley   +1 more source

Evaluating the Clinico-biochemical Association between Stress and Chronic Periodontitis by Estimation of Serum Cortisol and Serum Chromogranin A Levels

Advances in Human Biology
Introduction: Periodontitis is a persistent diseased condition of the oral tissues that manifests as loss of attachment. Alterations in immune, neural, endocrinal and behavioural systems caused by stressful life events may impair periodontal health ...
Shilpa Duseja, Hiral Akshat Parikh, Sareen Duseja   +2 more
doaj   +1 more source

Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues

مجلة كلية الطب, 2016
Background: Chromogranin A is a useful tumor marker for neuroendocrine tumors (NETs) diagnosis & follow-up, Octreotide (somatostatin-long acting repeatable (SAS-LAR)) is an established treatment for NETs.
Manwar A. Mohammed AL-Naqqash
doaj   +1 more source

Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors [PDF]

, 2018
Background. Neuroendocrine tumors (NETs) are characterized by having behavior and prognosis that depend upon tumor histology, primary site, staging, and proliferative index.
Baldelli, Roberto, Campana, Davide, Di Giacinto, Paola, Isidori, Andrea, Lania, Andrea, Lenzi, Andrea, Rizza, Laura, Rota, Francesca, Zuppi, Paolo   +8 more
core   +1 more source